These are top 10 stocks traded on the Robinhood UK platform in July
Frederick Wayne A.I., a director at Tempus AI , Inc. (NASDAQ:TEM), recently sold 3,000 shares of Class A common stock. The company, currently valued at $8.17 billion, has seen its stock surge nearly 40% year-to-date according to InvestingPro data. The transaction, which took place on March 31, was executed at a price of $45.54 per share, totaling $136,620. Following this sale, Wayne retains ownership of 26,514 shares in the company. The sale was conducted under a Rule 10b5-1 trading plan, which was adopted on September 12, 2024. While the stock has faced recent pressure, dropping 11% in the past week, InvestingPro analysis shows the company maintains a healthy liquidity position with a current ratio of 2.29, indicating strong ability to meet short-term obligations. InvestingPro subscribers have access to 8 additional key insights about TEM’s financial health and valuation metrics.
In other recent news, Tempus AI reported a robust 35.8% increase in revenue for the fourth quarter of 2024, reaching $700 million. However, the earnings per share (EPS) was negative at -0.18. Tempus AI has raised its revenue guidance for 2025 to approximately $1.24 billion, including contributions from its recent acquisition of Ambry Genetics. Stifel analysts maintained their Hold rating on Tempus AI, noting a $65 price target, while JPMorgan downgraded the stock from Overweight to Neutral but raised the price target to $55. Tempus AI also announced the acquisition of Deep 6 AI, aimed at enhancing its capabilities in AI-driven research platforms. This acquisition is expected to expand Tempus’s network and improve its existing applications. Despite facing some growth challenges, the company remains optimistic about its core business, projecting a 30% year-over-year growth driven by its diagnostic laboratory tests and genomics sector advancements.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.